Docoh
Loading...

LPTX Leap Therapeutics

News

From Benzinga Pro
48 Biggest Movers From Yesterday
21 Jan 22
News, Penny Stocks, Short Sellers, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
12 Health Care Stocks Moving In Wednesday's After-Market Session
19 Jan 22
Movers
Gainers Acorda Therapeutics (NASDAQ:ACOR) stock rose 6.7% to $1.92 during Wednesday's after-market session. The company's market cap stands at $21.5 million.
35 Stocks Moving In Wednesday's Mid-Day Session
19 Jan 22
News, Intraday Update, Markets, Movers, Trading Ideas
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
19 Jan 22
Pre-Market Outlook, Markets, Movers
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
19 Jan 22
Biotech, News, Penny Stocks, Guidance, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
Leap Therapeutics Says DKN-01 Combo Regime Show Compelling Efficacy In Gastric Cancer Patients
19 Jan 22
Biotech, News, Penny Stocks, Health Care, Movers, Trading Ideas, General
Leap Therapeutics Inc (NASDAQ: LPTX) will present
Leap Therapeutics To Present New Data From DisTinGuish Study Of DKN-01 Plus Tislelizumab At The ASCO GI Cancers Symposium
18 Jan 22
News, FDA
Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the Company will be presenting updated data from the DisTinGuish
Leap Therapeutics Q3 EPS $(0.14) Down From $(0.09) YoY
12 Nov 21
Earnings, News
Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.14) per share. This is a 55.56 percent decrease over losses of $(0.09) per share from the same period last year.

Press releases

From Benzinga Pro
Thinking about buying stock in Baudax Bio, Standard Lithium, KE Holdings, EHang Holdings, or Leap Therapeutics?
20 Jan 22
Opinion, Press Releases
NEW YORK, Jan. 20, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BXRX, SLI, BEKE, EH, and LPTX.
Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer
20 Jan 22
Opinion, Press Releases
- FinancialNewsMedia.com News Commentary - PALM BEACH, Fla., Jan. 20, 2022 /PRNewswire/ -- Despite significant progress in the treatment of gastric cancer, it is still among the leading causes of deaths due to cancer,
Thinking about buying stock in Zogenix, KE Holdings, SoFi Technologies, Leap Therapeutics, or ADMA Biologics?
19 Jan 22
Opinion, Press Releases
NEW YORK, Jan. 19, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZGNX, BEKE, SOFI, LPTX, and ADMA.
Leap Therapeutics to Present Positive New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ASCO GI Cancers Symposium
18 Jan 22
Press Releases
CAMBRIDGE, Mass., Jan. 18, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the Company will be
Leap Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference
5 Jan 22
Press Releases
CAMBRIDGE, Mass., Jan. 5, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi,
Leap Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
3 Jan 22
Press Releases
CAMBRIDGE, Mass., Jan. 3, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi,
Thinking about buying stock in Ocuphire Pharma, Seelos Therapeutics, Anavex Life Sciences, Leap Therapeutics, or Oramed Pharmaceuticals?
24 Nov 21
Small Cap, Opinion, Press Releases
NEW YORK, Nov. 24, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OCUP, SEEL, AVXL, LPTX, and ORMP.
Leap Therapeutics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference
15 Nov 21
Press Releases
CAMBRIDGE, Mass., Nov. 15, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that members of the
Leap Therapeutics Reports Third Quarter 2021 Financial Results
12 Nov 21
Earnings, Press Releases
CAMBRIDGE, Mass., Nov. 12, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for